CS logo
small CS logo
Rabin Medical Center-Beilinson Campus;Hematology-Oncology

Petach Tikva, Israel
Hospital in Petah Tikva
Jabotinski St 39, Petah Tikva, 4941492

About Rabin Medical Center-Beilinson Campus;Hematology-Oncology


Rabin Medical Center is a major hospital and medical center located in Petah Tikva, Israel. It is owned and operated by Clalit Health Services, Israel's largest health maintenance organization. In January 1996, Beilinson Hospital and Hasharon Hospital were merged and renamed Rabin Medical Center.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Rabin Medical Center-Beilinson Campus;Hematology-Oncology


During the past decade, Rabin Medical Center-Beilinson Campus;Hematology-Oncology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Surgery With or Without Combination Chemotherapy in Treating Patients With Liver Metastases From Colorectal Cancer
2000-09-01
Unknown status
Gemcitabine With/Out Erlotinib in Unresectable Locally Advanced/Metastatic Pancreatic Cancer
2001-10-29
2009-02-10
Completed
569
OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer.
2001-11-29
2004-01-15
Completed
569
A Study of Combination Thalidomide Plus Dexamethasone Therapy vs. Dexamethasone Therapy Alone in Previously Untreated Subjects With Multiple Myeloma
2003-02-01
2013-08-01
Completed
470
Carboplatin in Treating Patients With Stage IC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2004-03-01
2010-07-01
Completed
1,300
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600
A Randomised Trial of Preoperative Radiotherapy for Stage T3 Adenocarcinoma of Rectum
2001-07-01
2011-05-01
Completed
326

Rows per page:

1–71 of 71

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" #1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Rabin Medical Center-Beilinson Campus;Hematology-Oncology


According to Clinical.Site data, the most researched conditions in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" are "Leukemia, Myeloid, Acute" (1 trials), "Lymphocytic Leukemia, Chronic" (1 trials), "Lymphoma, Large B-Cell, Diffuse" (1 trials), "Malignant Melanoma" (1 trials) and "Non-Hodgkin's Lymphoma" (1 trials). Many other conditions were trialed in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" in a lesser frequency.

Clinical Trials Intervention Types at Rabin Medical Center-Beilinson Campus;Hematology-Oncology


Most popular intervention types in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Cyclophosphamide" (2 trials), "Obinutuzumab" (2 trials), "Placebo" (2 trials), "Rituximab" (2 trials) and "89Zr-Df-IAB22M2C" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Rabin Medical Center-Beilinson Campus;Hematology-Oncology


The vast majority of trials in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology" are 6 trials for "All" genders.

Clinical Trials Status at Rabin Medical Center-Beilinson Campus;Hematology-Oncology


Currently, there are NaN active trials in "Rabin Medical Center-Beilinson Campus;Hematology-Oncology". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Rabin Medical Center-Beilinson Campus;Hematology-Oncology, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Rabin Medical Center-Beilinson Campus;Hematology-Oncology, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status